Qumea provides a unique solution for discreet patient monitoring.
Qumea has raised €11M across 2 funding rounds from 3 investors, most recently a Series A round in Jan 2024. Based in Solothurn, Switzerland; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-01-30 | Series A | €9.6M | PB Invest,two family offices,Zürcher Kantonalbank | View deal → |
| 2021-04-07 | Seed | €1.6M | — | View deal → |